Literature DB >> 19710140

Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels.

Déborah Tribouillard-Tanvier1, James F Striebel, Karin E Peterson, Bruce Chesebro.   

Abstract

Activation of microglia and astroglia is seen in many neurodegenerative diseases including prion diseases. Activated glial cells produce cytokines as a protective response against certain pathogens and as part of the host inflammatory response to brain damage. In addition, cytokines might also exacerbate tissue damage initiated by other processes. In the present work using multiplex assays to analyze protein levels of 24 cytokines in scrapie agent-infected C57BL/10 mouse brains, we observed elevation of CCL2, CCL5, CXCL1, CXCL10, granulocyte-macrophage colony-stimulating factor (GM-CSF), gamma interferon (IFN-gamma), interleukin 1alpha (IL-1alpha), IL-1beta, IL-6, and IL-12p40. Scrapie agent-infected wild-type mice and transgenic mice expressing anchorless prion protein (PrP) had similar cytokine responses in spite of extensive differences in neuropathology. Therefore, these responses may be primarily a reaction to brain damage induced by prion infection rather than specific inducers of a particular type of pathology. To study the roles of astroglia and microglia in these cytokine responses, primary glial cultures were exposed to scrapie agent-infected brain homogenates. Microglia produced only IL-12p40 and CXCL10, whereas astroglia produced these cytokines plus CCL2, CCL3, CCL5, CXCL1, G-CSF, IL-1beta, IL-6, IL-12p70, and IL-13. Glial cytokine responses from wild-type mice and transgenic mice expressing anchorless PrP differed only slightly, but glia from PrP-null mice produced only IL-12p40, indicating that PrP expression was required for scrapie agent induction of other cytokines detected. The difference in cytokine response between microglia and astroglia correlated with 20-fold-higher levels of PrP expression in astroglia versus microglia, suggesting that high-level PrP expression on astroglia might be important for induction of certain cytokines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19710140      PMCID: PMC2772806          DOI: 10.1128/JVI.01413-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Immunocytochemical appearance of cytokines, prostaglandin E2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations.

Authors:  A Williams; A M Van Dam; D Ritchie; P Eikelenboom; H Fraser
Journal:  Brain Res       Date:  1997-04-18       Impact factor: 3.252

2.  Extracellular protein deposition correlates with glial activation and oxidative stress in Creutzfeldt-Jakob and Alzheimer's disease.

Authors:  Bart Van Everbroeck; Itte Dobbeleir; Michèle De Waele; Evelyn De Leenheir; Ursula Lübke; Jean-Jacques Martin; Patrick Cras
Journal:  Acta Neuropathol       Date:  2004-06-19       Impact factor: 17.088

3.  Tumor necrosis factor alpha-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie.

Authors:  N A Mabbott; A Williams; C F Farquhar; M Pasparakis; G Kollias; M E Bruce
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Subcellular localization of disease-associated prion protein in the human brain.

Authors:  Gábor G Kovács; Matthias Preusser; Michaela Strohschneider; Herbert Budka
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

5.  Anchorless prion protein results in infectious amyloid disease without clinical scrapie.

Authors:  Bruce Chesebro; Matthew Trifilo; Richard Race; Kimberly Meade-White; Chao Teng; Rachel LaCasse; Lynne Raymond; Cynthia Favara; Gerald Baron; Suzette Priola; Byron Caughey; Eliezer Masliah; Michael Oldstone
Journal:  Science       Date:  2005-06-03       Impact factor: 47.728

6.  Amino-terminally truncated prion protein PrP90-231 induces microglial activation in vitro.

Authors:  Stefano Thellung; Alessandro Corsaro; Valentina Villa; Valentina Venezia; Mario Nizzari; Michela Bisaglia; Claudio Russo; Gennaro Schettini; Antonio Aceto; Tullio Florio
Journal:  Ann N Y Acad Sci       Date:  2007-01       Impact factor: 5.691

7.  Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice.

Authors:  J I Kim; W K Ju; J H Choi; E Choi; R I Carp; H M Wisniewski; Y S Kim
Journal:  Brain Res Mol Brain Res       Date:  1999-11-10

Review 8.  Microglia and prion disease.

Authors:  D R Brown
Journal:  Microsc Res Tech       Date:  2001-07-15       Impact factor: 2.769

9.  Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice.

Authors:  Suzanne E Hickman; Elizabeth K Allison; Joseph El Khoury
Journal:  J Neurosci       Date:  2008-08-13       Impact factor: 6.167

10.  Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice.

Authors:  A E Williams; A M van Dam; W K Man-A-Hing; F Berkenbosch; P Eikelenboom; H Fraser
Journal:  Brain Res       Date:  1994-08-22       Impact factor: 3.252

View more
  36 in total

1.  Altered hippocampal synaptic transmission in transgenic mice with astrocyte-targeted enhanced CCL2 expression.

Authors:  Thomas E Nelson; Christine Hao; Jessica Manos; R M Ransohoff; Donna L Gruol
Journal:  Brain Behav Immun       Date:  2011-02-26       Impact factor: 7.217

2.  Identification of chemoattractive factors involved in the migration of bone marrow-derived mesenchymal stem cells to brain lesions caused by prions.

Authors:  Chang-Hyun Song; Osamu Honmou; Hidefumi Furuoka; Motohiro Horiuchi
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

3.  Statins are ineffective at reducing neuroinflammation or prolonging survival in scrapie-infected mice.

Authors:  James A Carroll; Brent Race; Katie Phillips; James F Striebel; Bruce Chesebro
Journal:  J Gen Virol       Date:  2017-07-31       Impact factor: 3.891

4.  Protective role of interferon regulatory factor 3-mediated signaling against prion infection.

Authors:  Daisuke Ishibashi; Ryuichiro Atarashi; Takayuki Fuse; Takehiro Nakagaki; Naohiro Yamaguchi; Katsuya Satoh; Kenya Honda; Noriyuki Nishida
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

5.  Activation of innate immune responses in the central nervous system during reovirus myelitis.

Authors:  Stephanie A Schittone; Kalen R Dionne; Kenneth L Tyler; Penny Clarke
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

6.  Region-specific glial homeostatic signature in prion diseases is replaced by a uniform neuroinflammation signature, common for brain regions and prion strains with different cell tropism.

Authors:  Natallia Makarava; Jennifer Chen-Yu Chang; Kara Molesworth; Ilia V Baskakov
Journal:  Neurobiol Dis       Date:  2020-01-27       Impact factor: 5.996

Review 7.  NLRs as Helpline in the Brain: Mechanisms and Therapeutic Implications.

Authors:  Shalini Singh; Sushmita Jha
Journal:  Mol Neurobiol       Date:  2018-03-06       Impact factor: 5.590

8.  IP10, KC and M-CSF Are Remarkably Increased in the Brains from the Various Strains of Experimental Mice Infected with Different Scrapie Agents.

Authors:  Jia Chen; Cao Chen; Chao Hu; Lian Liu; Ying Xia; Lin Wang; Wei Yang; Hai-Yan Wu; Wei Zhou; Kang Xiao; Qi Shi; Yuezhang Wu; Zhi-Bao Chen; Xiao-Ping Dong
Journal:  Virol Sin       Date:  2020-04-20       Impact factor: 4.327

9.  Apigenin as a Candidate Prenatal Treatment for Trisomy 21: Effects in Human Amniocytes and the Ts1Cje Mouse Model.

Authors:  Faycal Guedj; Ashley E Siegel; Jeroen L A Pennings; Fatimah Alsebaa; Lauren J Massingham; Umadevi Tantravahi; Diana W Bianchi
Journal:  Am J Hum Genet       Date:  2020-10-23       Impact factor: 11.025

10.  NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1β and neuronal toxicity.

Authors:  Iva Hafner-Bratkovič; Mojca Benčina; Katherine A Fitzgerald; Douglas Golenbock; Roman Jerala
Journal:  Cell Mol Life Sci       Date:  2012-08-29       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.